mafenide has been researched along with Brucellosis in 1 studies
Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, P | 1 |
| Turtaut, F | 1 |
| Ouahrani-Bettache, S | 1 |
| Montero, JL | 1 |
| Nishimori, I | 1 |
| Minakuchi, T | 1 |
| Vullo, D | 1 |
| Scozzafava, A | 1 |
| Köhler, S | 1 |
| Winum, JY | 1 |
| Supuran, CT | 1 |
1 other study available for mafenide and Brucellosis
| Article | Year |
|---|---|
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Clonin | 2010 |